Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
3.
Am J Forensic Med Pathol ; 19(4): 329-34, 1998 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9885926

RESUMEN

A case of accidental intracranial penetration of a 29-cm-long portion of nasogastric tube (NGT) in a 27-year-old female victim of a severe homicidal skull and brain trauma is reported. Accidental penetration of the NGT occurred through a large fracture of the ethmoid lamina cribrosa. In addition to a systematic review of previously reported cases, circumstantial data, clinical aspects, and autopsy data have been analyzed to draw medicolegal considerations concerning the connection between death and insertion of an NGT, which may also contribute to the ascertaining of any possible professional responsibility of medical staff, in a case fraught with numerous legal complications.


Asunto(s)
Traumatismos Craneocerebrales/complicaciones , Homicidio , Intubación Gastrointestinal , Adulto , Lesiones Encefálicas/diagnóstico por imagen , Traumatismos Craneocerebrales/diagnóstico por imagen , Resultado Fatal , Femenino , Humanos , Tomografía Computarizada por Rayos X
4.
J Clin Neurosci ; 5(3): 336-8, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18639043

RESUMEN

A 52-year-old man presented with sudden onset of severe headache, fever, mental confusion and mild signs of left hemisphere dysfunction. Computed tomographic and magnetic resonance imaging findings suggested a preoperative diagnosis of subependymoma of the left lateral ventricle, which was subsequently confirmed by surgery. The neoplasm could be totally removed and the postoperative clinical course was favourable. The reported case is unusual because symptomatic subependymomas of the lateral ventricle are definitely rare, and almost invariably present with a progressive clinical course over a period of weeks to years.

5.
J Neurosurg Sci ; 41(4): 401-8, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9555649

RESUMEN

Subependymomas are rare neuroectodermic tumours. The authors report a case of a patient he had a subendymoma in the left lateral ventricle, with particular attention to the MR aspects on these lesions and review of the literature.


Asunto(s)
Neoplasias del Ventrículo Cerebral/diagnóstico , Neoplasias del Ventrículo Cerebral/cirugía , Glioma Subependimario/diagnóstico , Glioma Subependimario/cirugía , Imagen por Resonancia Magnética , Encéfalo/patología , Humanos , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
6.
Cancer Genet Cytogenet ; 88(2): 95-102, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8640734

RESUMEN

To determine whether a correlation exists between aneuploidy and p53 status in astrocytic tumors we analyzed 48 astrocytomas with different grades of malignancy for the presence of p53 mutations and aneuploidy of chromosomes 10 and 17 (Ch10, Ch17), known to be particularly involved with this type of tumor. We used polymerase chain reaction (PCR)-based denaturing gradient gel electrophoresis (DGGE) analysis on exons 5-8 of the p53 gene, and fluorescence in situ hybridization (FISH) analysis on interphase nuclei using chromosome specific pericentromeric probes, respectively. Our results showed that Ch10/Ch17 aneuploidy is a common early event in astrocytomas (90% of low grade tumors are aneuploid). p53 mutations and Ch17 aneuploidy are early events, but their incidence is not dependent on tumor grade. Loss of Ch10 is the only alteration that significantly correlates with tumor progression. No significant correlation between the presence of Ch10/Ch17 aneuploidy and p53 mutations was found. However, the coexistence of p53 mutations and aneuploidy, was observed in a subset of cases. The presence of p53 mutations appeared to be a significant predictor of a poor prognosis. In conclusion, genomic instability may or may not be associated with p53 mutations in astrocytomas, thus suggesting that other cellular determinants can also be responsible for the aneuploidy observed.


Asunto(s)
Aneuploidia , Astrocitoma/genética , Neoplasias Encefálicas/genética , Deleción Cromosómica , Genes p53/genética , Glioblastoma/genética , Mutación Puntual/genética , Adulto , Anciano , Cromosomas Humanos Par 10/genética , Cromosomas Humanos Par 12/genética , Cromosomas Humanos Par 15/genética , Análisis Mutacional de ADN , Electroforesis en Gel de Poliacrilamida , Exones/genética , Femenino , Humanos , Hibridación Fluorescente in Situ , Masculino , Persona de Mediana Edad , Análisis de Regresión
7.
Anticancer Res ; 11(5): 1779-82, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1662925

RESUMEN

From June 1988 to January 1990, 28 patients with primary brain tumours were operated and treated with radiotherapy (RT) (50 Gy whole brain + 10 Gy boost to tumour bed) + cyclohexylnitrosourea (CCNU) 130 mg/msq p.o. every 6 weeks + the radiosensitizer Lonidamine (LND) (150 mg T.I.D. for the whole duration of treatment). Myelotoxicity of this regimen was acceptable, with two cases of grade IV leukopenia and thrombocytopenia requiring discontinuation of treatment. LND was discontinued in 6 patients for major toxicity (myalgias and/or testicular pain), and 3 additional patients required dose reduction of this drug. The median follow-up time of the patients on study was 12 months. The median survival time (MST) was 5 months for grade IV astrocytomas (n = 8) and 16 months for grade III lesions (= 20). No correlation was seen between survival of patients and DNA content, measured by flow cytometry, or levels of O6- alkylguanine-DNA alkyltransferase, an enzyme that repairs the CCNU-induced DNA damage.


Asunto(s)
Neoplasias Encefálicas/terapia , Glioblastoma/terapia , Indazoles/uso terapéutico , Lomustina/uso terapéutico , Fármacos Sensibilizantes a Radiaciones/uso terapéutico , Neoplasias Encefálicas/mortalidad , Neoplasias Encefálicas/radioterapia , Terapia Combinada , Femenino , Glioblastoma/mortalidad , Glioblastoma/radioterapia , Humanos , Masculino , Periodo Posoperatorio , Pronóstico
8.
Cancer Lett ; 55(2): 153-8, 1990 Dec 03.
Artículo en Inglés | MEDLINE | ID: mdl-2265415

RESUMEN

The O6-alkylguanine-DNA alkyltransferase (AT) activity in different kinds of human brain tumors was investigated. Twenty-seven brain tumors were analysed. Twenty-five of them showed proficient AT activity with values ranging between 20 and 722 fmol AT/mg protein. The two AT-deficient tumors observed were an oligodendroglioma and an astrocytoma. The relationship between the different histological kinds of tumor, with respect to the AT activity was: meningeomas greater than sarcomas greater than glioblastomas greater than astrocytomas greater than oligodendrogliomas greater than neurinomas greater than lymphomas. The proposal of Kohn (DNA filter elution methods in anticancer drug development. In: Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy. Editor: F.M. Muggia. Martinus Nijhoff Publishers, Boston) to confine treatments with alkylating antineoplastic agents to AT-deficient tumors, is discussed.


Asunto(s)
Astrocitoma/enzimología , Neoplasias Encefálicas/enzimología , Glioma/enzimología , Meningioma/enzimología , Metiltransferasas/metabolismo , Animales , Astrocitoma/patología , Neoplasias Encefálicas/patología , Cromatografía Líquida de Alta Presión/métodos , Reparación del ADN , ADN de Neoplasias/metabolismo , Glioma/patología , Humanos , Meningioma/patología , Metilnitrosourea/metabolismo , O(6)-Metilguanina-ADN Metiltransferasa , Purinas/metabolismo , Reproducibilidad de los Resultados , Tritio
9.
Boll Soc Ital Biol Sper ; 66(5): 495-8, 1990 May.
Artículo en Italiano | MEDLINE | ID: mdl-2168722

RESUMEN

We have started a study to measure the MT activity in surgical specimens from high grade human malignant gliomas, with the dual aim to (i), know whether lack of activity can be demonstrated in these tumors, and (ii), relate the measured levels of MT to the histology of the tumors and to the response of patients to chemotherapy with 1-(2-Chloroethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU). To date, 12 Gliomas have been assayed. In 11 tumors, MT activities ranging from 30 to 150 fmoles/mg protein have been measured. The only negative specimen derived from a patient who had received radiotherapy before surgery. At the present stage of the study, therefore, we have no unequivocal evidence for the existence of MT-deficient Gliomas.


Asunto(s)
Astrocitoma/tratamiento farmacológico , Neoplasias Encefálicas/tratamiento farmacológico , Glioblastoma/tratamiento farmacológico , Lomustina/uso terapéutico , Metiltransferasas/metabolismo , Astrocitoma/enzimología , Astrocitoma/patología , Neoplasias Encefálicas/enzimología , Neoplasias Encefálicas/patología , Femenino , Glioblastoma/enzimología , Glioblastoma/patología , Humanos , Masculino , Estadificación de Neoplasias , O(6)-Metilguanina-ADN Metiltransferasa
10.
Minerva Anestesiol ; 55(1-2): 11-9, 1989.
Artículo en Italiano | MEDLINE | ID: mdl-2779807

RESUMEN

Pre- and postoperative serum CK activity is evaluated in 142 children submitted, "uneventfully", to diagnostic muscle biopsy under halothane (77 patients), ketamine (50 patients) or "local" (15 patients) anaesthesia. The purpose was to ascertain whether or not anaesthesia-induced-rhabdomyolysis (AR) was an asymptomatic (and unrecognized) complication of "uneventful" anaesthesia. The majority of patients with low preoperative CK values showed a slight increase of serum CK activity on the first postoperative day. On the contrary, a postoperative decrease was observed in the majority of patients with high preoperative values (namely in almost all ketamine patients and in 2/3 of halothane-patients). In no case postoperative increase reached a value suggesting the occurrence of AR even though a postoperative value of 16480 U/I was observed in a patient with Duchenne muscular dystrophy after halothane anaesthesia. Sudden interruption of motor activity induced by general anaesthesia seems to be the most important factor in reducing the release of CK from muscle. When preoperative release is low, any further postoperative reduction is not sufficient to balance the moderate increase of CK produced by the surgical procedure; the opposite should happen in patients presenting with high preoperative release. So far as anaesthetics are concerned, our data seem to suggest that ketamine has a higher "protective" role compared to halothane.


Asunto(s)
Anestesia General/efectos adversos , Anestesia Local/efectos adversos , Pruebas Enzimáticas Clínicas , Creatina Quinasa/sangre , Rabdomiólisis/diagnóstico , Biopsia , Niño , Preescolar , Femenino , Halotano , Humanos , Ketamina , Masculino , Enfermedades Musculares/patología , Cuidados Posoperatorios , Cuidados Preoperatorios , Rabdomiólisis/sangre
11.
Int J Artif Organs ; 10(5): 315-8, 1987 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3679573

RESUMEN

Thirty-seven myasthenic patients were treated with therapeutic plasma exchange (TPE) on different performance schedules using either random or single donor plasma. The two schedules had the same effects in terms of efficacy but single donor replacement gave significantly less side effects in the short and long term. A two exchange procedure on alternate days associated with immunosuppression seems to be an optimal schedule for the treatment of myasthenic patients. A single donor two-exchange on alternate days procedure appears to be safe, useful and can be repeated in patients who need frequent TPE.


Asunto(s)
Donantes de Sangre , Miastenia Gravis/terapia , Intercambio Plasmático , Adolescente , Adulto , Anciano , Femenino , Hepatitis Viral Humana/transmisión , Humanos , Masculino , Persona de Mediana Edad , Volumen Plasmático , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA